Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsLudovico Arcuri(University of Ferrara), Michele Morari(University of Ferrara)British Journal of PharmacologyDecember 13, 201710.1111/bph.14123Cited by 22SaveCiteExport RISWatch citationsRelated PapersNociceptin/Orphanin FQ Receptor Agonists Attenuate l-DOPA-Induced Dyskinesias|Journal of Neuroscience|2012|42RGS4 negatively modulates Nociceptin/Orphanin FQ opioid receptor signaling: implication for L-Dopa induced dyskinesia|Unknown|2021|0